Miriam is a seasoned professional in Health and Law, specializing in Sanitary Regulation and Clinical Research. With over 20 years of experience, she has a track record in planning and executing global, regional, and local clinical development programs, including Bioequivalence studies and Phase I-IV clinical trials. Her expertise spans Clinical Monitoring, Quality Assurance, Budgeting, Contracts & Payments Control, Clinical Trial Supplies, Master File, Pharmacovigilance, and Regulatory Affairs within both pharmaceutical industries and CROs, at national and international levels. She is recognized in the sector as a key opinion leader and a local expert in regulatory matters. Her leadership and active participation in gremial improvement initiatives have been pivotal, building synergies with authorities, academic, and industrial colleagues to further the development and progress of Clinical Research.
Miriam Serrano, Clinical Research Expert
Newsletter
Get the Global Trial Accelerators™ newsletter
Practical insights on first-in-human and early feasibility trials across medtech, biotech/biopharma and radiopharma, in your inbox.
Free. Unsubscribe anytime. See the bioaccess® Privacy Policy (opens in a new tab) and the newsletter platform's Terms of Service (opens in a new tab).
Recent Episodes
- Varun Kalaiarasan, PhD Researcher at University of Cincinnati
- Ryan Beal, Chief Executive Officer at Dyve Biosciences
- Sandi Schaible, Founder & President at Bonded in Science
- Gennaro Maida, CEO and Founder at Denovo Innovations Group
- Benjamin Holmes, Chief Executive Officer at Nanochon
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- See all →